SCPH — SCPHARMACEUTICALS ORD

Ownership history in Trium Capital LLP  ·  1 quarter on record

This page tracks every 13F SEC filing in which Trium Capital LLP reported a position in SCPHARMACEUTICALS ORD (SCPH). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.07% (2025 Q3)
Avg. % of fund
0.07%
First filed
2025 Q3
Last filed
2025 Q3
Quarters held
1
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 INITIATED 32,710 — — 0.07% $185K —
% of Fund (quarterly)

Other funds also holding SCPH

As of 2025 Q3 — sorted by position size

Yakira Capital Management, Inc. 3Y 7Y 0.87% ORBIMED ADVISORS LLC 3Y 7Y 0.81% Tejara Capital Ltd 3Y 0.73% Newtyn Management, LLC 3Y 7Y 0.65% APIS CAPITAL ADVISORS, LLC 3Y 7Y 0.55% Rangeley Capital, LLC 0.46% Balanced Rock Investment Advisors LLC 0.34% ALPINE ASSOCIATES MANAGEMENT INC. 3Y 7Y 0.33% Rubric Capital Management LP 3Y 7Y 0.33% GABELLI & Co INVESTMENT ADVISERS, INC. 3Y 7Y 0.28%
← Back to Trium Capital LLP Holdings